NorthWest Biotherapeutics Inc (NWBO)

[gnawkz]

Hi LongUSA,

I am on the same page regarding the fact that reimbursement negotiations will have to be finalized prior to any significant revenue from Germany. My main thought was around why there have been no "one-off" revenues since the announcement of the Hospital Exemption status.

Considering the aggressive nature of GBM and the fact that Hospital Exemption covered all types of GBM, I am a little surprised to see no revenues for this most recent quarter.

But your point about US compassionate use and how the treatment has been provided for no charge has changed my thought process. It looks like if there were patients treated under the Hospital Exemption program, these patients were treated without charge also.

I have been focused on this area for a while because the Hospital Exemption program is so NEW. It makes me consider these other variables regarding the future short term success of DCVax-L under hospital exemption:
- The short life span of the program makes me wonder how many doctors and hospitals are actively aware of this program and the ability to access clinical treatments still in trial.
- Next, if the program is so new, how many doctors will actually recommend the treatments under this program
- What kind of information infrastructure is currently available to the doctors so that they can learn more about the program and treatment considering the fact that NWBO is not allowed to do any kind of marketing what so ever.

Thanks for clearing up all my other misconceptions Long